131 related articles for article (PubMed ID: 28060290)
21. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.
Montoro E; Lemus D; Echemendia M; Martin A; Portaels F; Palomino JC
J Antimicrob Chemother; 2005 Apr; 55(4):500-5. PubMed ID: 15731200
[TBL] [Abstract][Full Text] [Related]
22. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and dose response of anti-TB drugs in rat infection model of tuberculosis.
Kumar N; Vishwas KG; Kumar M; Reddy J; Parab M; Manikanth CL; Pavithra BS; Shandil RK
Tuberculosis (Edinb); 2014 May; 94(3):282-6. PubMed ID: 24629633
[TBL] [Abstract][Full Text] [Related]
24. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes.
Coban AY; Cekic Cihan C; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
J Chemother; 2006 Apr; 18(2):140-3. PubMed ID: 16736881
[TBL] [Abstract][Full Text] [Related]
25. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
[TBL] [Abstract][Full Text] [Related]
26. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs.
Martin A; Morcillo N; Lemus D; Montoro E; Telles MA; Simboli N; Pontino M; Porras T; León C; Velasco M; Chacon L; Barrera L; Ritacco V; Portaels F; Palomino JC
Int J Tuberc Lung Dis; 2005 Aug; 9(8):901-6. PubMed ID: 16104638
[TBL] [Abstract][Full Text] [Related]
27. Automation of the resazurin reduction test using fluorometry of microtitration trays.
Ali-Vehmas T; Louhi M; Sandholm M
Zentralbl Veterinarmed B; 1991 Jul; 38(5):358-72. PubMed ID: 1927150
[TBL] [Abstract][Full Text] [Related]
28. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
Darby CM; Nathan CF
J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
[TBL] [Abstract][Full Text] [Related]
29. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
[TBL] [Abstract][Full Text] [Related]
30. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
31. Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.
Naran K; Moosa A; Barry CE; Boshoff HI; Mizrahi V; Warner DF
Antimicrob Agents Chemother; 2016 Nov; 60(11):6748-6757. PubMed ID: 27572410
[TBL] [Abstract][Full Text] [Related]
32. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
Abe C
Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
[TBL] [Abstract][Full Text] [Related]
33. Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes.
Sungkanuparph S; Pracharktam R; Thakkinstian A; Buabut B; Kiatatchasai W
J Med Assoc Thai; 2002 Jul; 85(7):820-4. PubMed ID: 12296415
[TBL] [Abstract][Full Text] [Related]
34. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
35. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
36. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
[TBL] [Abstract][Full Text] [Related]
37. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis.
Lemus D; Martin A; Montoro E; Portaels F; Palomino JC
J Antimicrob Chemother; 2004 Jul; 54(1):130-3. PubMed ID: 15190018
[TBL] [Abstract][Full Text] [Related]
38. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
39. Comment on: Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
Imkamp F; Keller PM; Böttger EC
J Antimicrob Chemother; 2016 Dec; 71(12):3624. PubMed ID: 27530753
[No Abstract] [Full Text] [Related]
40. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
